- Home
- HCWB vs SDOT Comparison
HCWB vs SDOT Comparison
Compare HCWB & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- SDOT
- Stock Information
- Founded
- HCWB 2018
- SDOT 2014
- Country
- HCWB United States
- SDOT United States
- Employees
- HCWB N/A
- SDOT N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- SDOT Restaurants
- Sector
- HCWB Health Care
- SDOT Consumer Discretionary
- Exchange
- HCWB Nasdaq
- SDOT Nasdaq
- Market Cap
- HCWB 17.2M
- SDOT 16.5M
- IPO Year
- HCWB 2021
- SDOT 2020
- Fundamental
- Price
- HCWB $0.34
- SDOT $3.02
- Analyst Decision
- HCWB
- SDOT Hold
- Analyst Count
- HCWB 0
- SDOT 1
- Target Price
- HCWB N/A
- SDOT N/A
- AVG Volume (30 Days)
- HCWB 281.9K
- SDOT 21.4K
- Earning Date
- HCWB 03-31-2025
- SDOT 03-19-2025
- Dividend Yield
- HCWB N/A
- SDOT N/A
- EPS Growth
- HCWB N/A
- SDOT N/A
- EPS
- HCWB N/A
- SDOT 0.35
- Revenue
- HCWB $3,495,990.00
- SDOT $655,938,000.00
- Revenue This Year
- HCWB $229.19
- SDOT $1.20
- Revenue Next Year
- HCWB N/A
- SDOT $29.55
- P/E Ratio
- HCWB N/A
- SDOT $9.18
- Revenue Growth
- HCWB 22.27
- SDOT N/A
- 52 Week Low
- HCWB $0.21
- SDOT $2.24
- 52 Week High
- HCWB $2.52
- SDOT $7.00
- Technical
- Relative Strength Index (RSI)
- HCWB 46.07
- SDOT 46.17
- Support Level
- HCWB $0.33
- SDOT $2.90
- Resistance Level
- HCWB $0.38
- SDOT $3.24
- Average True Range (ATR)
- HCWB 0.03
- SDOT 0.25
- MACD
- HCWB -0.00
- SDOT -0.01
- Stochastic Oscillator
- HCWB 33.18
- SDOT 29.50
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.